Novo Holdings
VC
INVESTOR TYPE
Active
STATUS
61
PROFESSIONALS
347
INVESTMENTS
99
PORTFOLIO
136
EXITS
Description
Founded in 1999, Novo Holdings is a corporate venture arm of the Novo Nordisk Foundation headquartered in Hellerup, Denmark. The firm is the holding company for the Novo Group. The firm seeks to invest in the biotechnology, healthcare and life sciences sectors.
Website
Formerly Known As
Nova A/S
Investor Status
Actively Seeking New Investments
Year Founded
1999
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Real Estate
Venture Capital
Primary Office
- Tuborg Havnevej 19
- 2900 Hellerup
- Denmark
+45 35 00 00 00
Novo Holdings Investments (347)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Tempus | 30-May-2019 | Later Stage VC | 00000 | Outcome Management (Healthcare) | Generating Revenue | 000000 00000000 |
| 000000 000000000 | 28-May-2019 | 0000 0000000 | 000.00 | Biotechnology | Profitable | |
| 00000000 | 06-May-2019 | 00000 00000 | 0000 | Agricultural Chemicals | Generating Revenue | 000000 00000 00.0 |
| 0000000 000000 | 10-Apr-2019 | 00000 00000 | 0000 | Biotechnology | Startup | 000000 0000000 00 |
| 0000 0000000000000 | 05-Feb-2019 | 00000 00000 | 0000 | Biotechnology | Startup | 00000 00000 00.0 |
| 00000000 | 21-Jan-2019 | 00000 00000 | 00.000 | Biotechnology | Clinical Trials - Phase 1 | 00000 0ü000000 00.0 |
| 00000 000000000 00 | 01-Jan-2019 | 0000000000 | Outcome Management (Healthcare) | Generating Revenue | 0000000 000000 00 | |
| 0000000 0000000000 | 18-Dec-2018 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 0000 0000000 00.0 |
| Camel-IDS | 16-Nov-2018 | Early Stage VC | 000.00 | Biotechnology | Startup | 000000 0ø00000 |
| Mirum Pharmaceuticals | 07-Nov-2018 | Early Stage VC | 00000 | Drug Discovery | Clinical Trials - Phase 3 | 0000 0000000 00.0 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Novo Holdings’s full profile, request a free trial.
Novo Holdings Exits (131)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals | 13-May-2019 | IPO | 000.00 | Completed |
|
| 0000000 0000000000 | 22-Jan-2019 | 000000000000000000 | 00000 | Completed |
|
| 000000 0000000 | 13-Nov-2018 | 000000000000000000 | 00000 | Completed |
|
| 00-0000 | 17-Oct-2018 | 000 | 00000 | Completed |
|
| 0000000 0000000000 | 26-Sep-2018 | 000 | 0000 | Completed |
|
| 0000000 | 19-Jul-2018 | 000 | 00000 | Completed |
|
| 000 000000000 0000 | 08-Jun-2018 | 000000000 00000000 | Completed |
|
|
| 00 000000000000000 | 13-Apr-2018 | 000000000 00000000 | Completed |
|
|
| UNUM Therapeutics | 29-Mar-2018 | IPO | 000.00 | Completed |
|
| iRhythm Technologies | 29-Mar-2018 | Secondary Transaction - Open Market | Completed |
|
Novo Holdings Team (98)
34 Former Team Members
You’re viewing 5 of 98 team members. Get the full list »Novo Holdings Co-Investors (228)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| New Enterprise Associates | 9 | 00 | |
| OrbiMed | 0 | 00 | |
| Novartis Venture Fund | 0 | 00 | |
| Rock Springs Capital | 0 | 0 | |
| Vivo Capital | 0 | 0 |